Document is current
Any future updates will be listed below
-
Authors
Tsujikawa, Laura M.
Fu, Li
Das, Shovon
Halliday, Christopher
Rakai, Brooke D.
Stotz, Stephanie C.
Sarsons, Christopher D.
Gilham, Dean
Daze, Emily
Wasiak, Sylwia
Studer, Deborah
Rinker, Kristina D.
Sweeney, Michael
Johansson, Jan O.
Wong, Norman C. W.
Kulikowski, Ewelina https://orcid.org/0000-0001-5428-3008
- License Information
-
More Information
Article History
Received: 2 April 2019
Accepted: 11 June 2019
First Online: 12 July 2019
Ethics approval and consent to participate
: The ASSURE study (NCT01067820) design and rationale has been published previously []. Briefly, it was a phase II, placebo-controlled, multi-center, double-blind study. The study was conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all study participants.
: Not applicable.
: All authors that are Resverlogix employees receive salaries and shares from the company.
